Investigating the Role of Osteopontin as a Potential Biomarker in Relapsing-Remitting Multiple Sclerosis

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 42

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TBSRJ-7-3_004

تاریخ نمایه سازی: 28 دی 1404

چکیده مقاله:

Introduction: Multiple sclerosis is a chronic central nervous system disorder with an unknown etiology. Osteopontin is a pro-inflammatory cytokine that has been implicated in MS pathogenesis. This study aimed to investigate OPN levels in relapsing-remitting MS patients and compare them with healthy individuals to determine its potential role as a biomarker. Methods: A case-control study was conducted on MS patients referred to BooAli Hospital in Sari. Fifty relapsing-remitting MS patients and ۳۰ healthy controls were included. Plasma OPN levels were assessed using ELISA kits, and we considered the p-value < ۰.۰۵ significant. Findings: Among the participants, the MS group was composed of ۳۰ women (۶۰%) and ۲۰ men (۴۰%), while the healthy group comprised ۲۰ women (۶۶.۷%) and ten men (۳۳.۳%). Notably, OPN levels were significantly elevated in the MS group compared to the healthy individuals (p-value < ۰.۰۰۱). No difference in OPN levels was observed between male and female MS patients (p-value = ۰.۴). A significant inverse correlation was also identified between the EDSS score and OPN levels (p-value = ۰.۰۱). Conclusion: This study demonstrates elevated OPN levels in relapsing-remitting MS patients compared to healthy individuals, suggesting its potential as a biomarker for disease activity in MS.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Ghasemi N, Razavi S, Nikzad E. Multiple Sclerosis: Pathogenesis, Symptoms, ...
  • Walton C, King R, Rechtman L, Kaye W, Leray E, ...
  • Jobin C, Larochelle C, Parpal H, Coyle PK, Duquette P. ...
  • Frouzanian M, Jafarpour H, Razavi A, Abdollahi A. Multiple sclerosis ...
  • Lund SA, Giachelli CM, Scatena M. The role of osteopontin ...
  • Alikhani A, Ahmadi N, Frouzanian M, Abdollahi A. Motor polyradiculoneuropathy ...
  • Wang KX, Denhardt DT. Osteopontin: role in immune regulation and ...
  • Najafi N, Razavi A, Jafarpour H, Raei M, Azizi Z, ...
  • Agah E, Zardoui A, Saghazadeh A, Ahmadi M, Tafakhori A, ...
  • Orsi G, Hayden Z, Cseh T, Berki T, Illes Z. ...
  • Börnsen L, Khademi M, Olsson T, Sørensen PS, Sellebjerg F. ...
  • Jafarinia M, Sadeghi E, Alsahebfosoul F, Etemadifar M, Jahanbani-Ardakani H. ...
  • Comi C, Cappellano G, Chiocchetti A, Orilieri E, Buttini S, ...
  • Barizzone N, Marchini M, Cappiello F, Chiocchetti A, Orilieri E, ...
  • Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, ...
  • Chowdhury SA, Lin J, Sadiq SA. Specificity and correlation with ...
  • Braitch M, Constantinescu CS. The role of osteopontin in experimental ...
  • Rittling SR, Singh R. Osteopontin in Immune-mediated Diseases. J Dent ...
  • O'Regan AW, Hayden JM, Berman JS. Osteopontin augments CD۳-mediated interferon-gamma ...
  • Vogt MH, Lopatinskaya L, Smits M, Polman CH, Nagelkerken L. ...
  • Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, ...
  • Stampanoni Bassi M, Buttari F, Gilio L, Iezzi E, Galifi ...
  • Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl ...
  • Yu H, Liu X, Zhong Y. The Effect of Osteopontin ...
  • Szalardy L, Zadori D, Simu M, Bencsik K, Vecsei L, ...
  • Clemente N, Comi C, Raineri D, Cappellano G, Vecchio D, ...
  • Iaffaldano P, Ruggieri M, Viterbo RG, Mastrapasqua M, Trojano M. ...
  • نمایش کامل مراجع